Hoo Jae Hann
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Hoo Jae Hann has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Hyeong Sik Ahn
Cochrane Korea, Seoul, Korea
4 shared publications Kyoung Hoon Kim
Department of Public Health, Graduate School, Korea University, Seoul, Republic of Korea; Health Insurance Review and Assessment Service, Republic of Korea
4 shared publicationsHyun Jung Kim
Department of Preventive Medicine, College of Medicine, Korea University, Seoul, Republic of Korea
3 shared publicationsSeungjin Han
Department of Public Health, Graduate School, Korea University, Seoul, Republic of Korea; Health Insurance Review and Assessment Service, Republic of Korea
3 shared publicationsYuri Kim
Department of Public Health, Graduate School, Korea University, Seoul, Republic of Korea; Health Insurance Review and Assessment Service, Republic of Korea
3 shared publicationsHojong Park
Department of Surgery, University of Ulsan College of Medicine, Republic of Korea
2 shared publications
Latest Publications
- 1 October 2017
- Published by Elsevier in Seminars in Arthritis and Rheumatism
- Vol. 47 (2) , 222-227
Incidence, mortality, and causes of death in physician-diagnosed primary Sjögren’s syndrome in Korea: A nationwide, population-based study
- 1 October 2017
- Published by Elsevier in Seminars in Arthritis and Rheumatism
- Vol. 47 (2) , 222-227
Incidence, mortality, and causes of death in physician-diagnosed primary Sjögren’s syndrome in Korea: A nationwide, population-based study
- Open Access
- 22 July 2017
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 178 (1) , e37-e39
Incidence, prevalence, mortality and causes of death in systemic sclerosis in Korea: a nationwide population‐based study
- 22 July 2017
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 178 (1) , e37-e39
Open AccessIncidence, prevalence, mortality and causes of death in systemic sclerosis in Korea: a nationwide population‐based study
- 1 May 2017
- Published by Elsevier in International Journal of Cardiology
- Vol. 235, 100-104
Incidence, prevalence, mortality and causes of death in Takayasu Arteritis in Korea – A nationwide, population-based study
- 1 May 2017
- Published by Elsevier in International Journal of Cardiology
- Vol. 235, 100-104
Incidence, prevalence, mortality and causes of death in Takayasu Arteritis in Korea – A nationwide, population-based study
- 1 April 2014
- Published by Wolters Kluwer Health in Stroke
- Vol. 45 (4) , 1090-1095
Incidence, Prevalence, and Survival of Moyamoya Disease in Korea
Background and Purpose—: There is a scarcity of information on the epidemiology and natural course of moyamoya disease. The aim of this study was to investigate the nationwide epidemiological features of moyamoya disease in Korea, including incidence, prevalence, and survival. Methods—: We used the data from nationwide, population-based Health Insurance Review and Assessment Service claims database and Rare Intractable Disease registration program, which includes physician-certified diagnoses based on uniform criteria for moyamoya disease from 2007 to 2011. Age-specific incidence and prevalence were calculated, and survival was examined using Kaplan–Meier method. Results—: The total number of patients with moyamoya disease was 8154 in 2011, with a female-to-male ratio of 1.8. The incidence from 2007 to 2011 was 1.7 to 2.3/10 5 , and the prevalence in 2011 was 16.1/10 5 . In total, 66.3% of patients aged 0 to 14 years underwent surgery, whereas only 21.5% in the older than 15 years age group underwent surgery. The 1- and 5-year survival rates of adult patients were 96.9% and 92.9%, respectively, and of child patients were 99.6% and 99.3%, respectively. Conclusions—: The prevalence and incidence presented in this study are higher than those in previous studies. This study demonstrates that the burden of moyamoya disease in Korea is substantial.
- 1 April 2014
- Published by Wolters Kluwer Health in Stroke
- Vol. 45 (4) , 1090-1095
Incidence, Prevalence, and Survival of Moyamoya Disease in Korea
Background and Purpose—: There is a scarcity of information on the epidemiology and natural course of moyamoya disease. The aim of this study was to investigate the nationwide epidemiological features of moyamoya disease in Korea, including incidence, prevalence, and survival. Methods—: We used the data from nationwide, population-based Health Insurance Review and Assessment Service claims database and Rare Intractable Disease registration program, which includes physician-certified diagnoses based on uniform criteria for moyamoya disease from 2007 to 2011. Age-specific incidence and prevalence were calculated, and survival was examined using Kaplan–Meier method. Results—: The total number of patients with moyamoya disease was 8154 in 2011, with a female-to-male ratio of 1.8. The incidence from 2007 to 2011 was 1.7 to 2.3/10 5 , and the prevalence in 2011 was 16.1/10 5 . In total, 66.3% of patients aged 0 to 14 years underwent surgery, whereas only 21.5% in the older than 15 years age group underwent surgery. The 1- and 5-year survival rates of adult patients were 96.9% and 92.9%, respectively, and of child patients were 99.6% and 99.3%, respectively. Conclusions—: The prevalence and incidence presented in this study are higher than those in previous studies. This study demonstrates that the burden of moyamoya disease in Korea is substantial.